ELAN News and Press, Elanco Animal Health Incorporated From 06/21/21

The remote lifestyle forced by the COVID-19 pandemic boosted pet ownership over the past year. As a result, the pet industry has been faced with huge demand for pet food and medications. In response to this, pet companies are racing to develop quality food products and viable drugs and diagno...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the rise of the Reddit army and meme stock trading, penny stocks have been in focus. There are some penny stocks that are purely speculative. However, there are others with decent fundamentals. Given the current in...

Marko Geber/DigitalVision via Getty Images Elanco Animal Health's (ELAN) $440M deal for Kindred BioSciences (KIN) could better position the company to compete against Zoetis (ZTS) in the pet dermatology space, Barron's reports. Dermatology is a fast-growing pet care segment as evidenced by th...

Shares of Kindred Biosciences (NASDAQ: KIN) soared 46% on Wednesday after the pet-focused biotech company said it agreed to be acquired by Elanco Animal Health (NYSE: ELAN) . The deal values KindredBio at roughly $440 million, or $9.25 per share. That's a premium of ...

Elanco Animal Health Inc ( NYSE: ELAN ) said on Wednesday it will acquire Kindred Biosciences Inc ( NASDAQ: KIN ) for roughly $440 million (£312 million) to expand its footprint in the pet health industry. The acquisition will bring three potential dermatology blockbusters,...

The DraftKings (DKNG) saga continued Wednesday morning, as a well-known investor grabbed the online gaming company's stock after Tuesday's decline.Oracle (ORCL) dropped in Wednesday's pre-market action, despite the release of better-than-expected quarterly results. Concerns about the firm's c...

Elanco Animal Health (ELAN) inks agreement to acquire Kindred Biosciences (KIN) have which will further accelerates Elanco's expansion in pet health market.Under the terms of the deal, Elanco will acquire all outstanding stock of Kindred at $9.25/share, or ~$440M.KindredBio brings three poten...

Elanco Announces Agreement to Acquire Kindred Biosciences Bolt-on Acquisition Accelerates Elanco's Expansion in Pet Health Elanco to host conference call for investment community at 8:00 am Eastern Time -- Elanco will acquire all outstanding stock of Kindred Biosciences ...

Elanco posted strong revenue growth. Impairment charge and restructuring a near-term headwind. Stock rated a hold after the rally from March Lows. For further details see: Hold Elanco Despite Litigation Risks

Elanco Animal Health (ELAN) has inked agreement to sell its two facilities to contract development and manufacturing organization, TriRx Pharmaceutical Services.The sites are located in Shawnee, Kansas and Speke, U.K., and will expand the manufacturing footprint of TriRx, adding to ...